Tinavi Medical Technologies Co., Ltd. (SHA:688277)
China flag China · Delayed Price · Currency is CNY
15.02
-0.47 (-3.03%)
Sep 14, 2026, 3:00 PM CST

SHA:688277 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
228.74264.15260.2310.86211.39287.11
Short-Term Investments
--26.6---
Trading Asset Securities
17.0141.65-50.0440.2120.63
Cash & Short-Term Investments
245.74305.8286.79360.9251.59407.74
Cash Growth
-25.14%6.63%-20.53%43.45%-38.30%-43.42%
Accounts Receivable
53.0642.0270.9649.6635.3737.52
Other Receivables
10.7910.3412.539.5211.8510.16
Receivables
63.8552.3683.4959.1847.2347.68
Inventory
68.247.2931.6726.2343.837.94
Prepaid Expenses
----2.992.75
Other Current Assets
37.637.4536.0242.4927.811.3
Total Current Assets
415.39442.89437.97488.8373.41507.42
Property, Plant & Equipment
438.38430.39422.67450.35279.47112.35
Long-Term Investments
598.62617.67596.02454.34467.02265.22
Other Intangible Assets
36.8441.9116.3410.286.697.61
Long-Term Accounts Receivable
17.0315.728.251.65-3.41
Long-Term Deferred Tax Assets
9.249.1454.1977.878654.16
Long-Term Deferred Charges
32.1815.3232.5413.8519.3820.23
Other Long-Term Assets
135.54141.3123.73122.34174.98308.64
Total Assets
1,6831,7141,6921,6191,4071,279

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
54.9544.5527.8427.7922.529.63
Accrued Expenses
14.0631.9535.6543.1753.7337.83
Short-Term Debt
2016.3825.7832.81--
Current Portion of Long-Term Debt
21.6921.218.1920.683.29-
Current Portion of Leases
1.781.923.944.933.4722.59
Current Unearned Revenue
28.1842.1538.6617.6132.1131.56
Other Current Liabilities
5.525.436.5320.0813.2611.62
Total Current Liabilities
146.17163.58156.6167.04158.38113.23
Long-Term Debt
143.24154.25150.37157.7521.25-
Long-Term Leases
2.613.350.263.7540.4148.17
Long-Term Unearned Revenue
1.251.537.214.3111.820.7
Long-Term Deferred Tax Liabilities
53.3653.6157.8942.2552.3722.56
Other Long-Term Liabilities
113.97112.0139.246.855.186.82
Total Liabilities
460.6488.34411.58381.95289.39211.48

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
466.44455.99449.39449.39419.85419.85
Additional Paid-In Capital
1,2111,1431,0451,031668.47670.68
Retained Earnings
-805.46-735.36-551.92-467.22-310.83-192.12
Comprehensive Income & Other
321.08322.47325.47224.81266.2108.54
Total Common Equity
1,1931,1861,2681,2381,0441,007
Minority Interest
29.4139.5212.29-73.8860.62
Shareholders' Equity
1,2231,2261,2801,2381,1181,068
Total Liabilities & Equity
1,6831,7141,6921,6191,4071,279

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
189.32197.09198.54219.8998.4270.76
Net Cash (Debt)
56.42108.7188.25141.01153.17336.98
Net Cash Growth
-49.55%23.18%-37.42%-7.94%-54.55%-53.24%
Net Cash Per Share
0.120.240.200.320.360.80
Filing Date Shares Outstanding
466.44455.99449.39449.39419.85419.85
Total Common Shares Outstanding
466.44455.99449.39449.39419.85419.85
Working Capital
269.22279.31281.37321.76215.03394.19
Book Value Per Share
2.562.602.822.752.492.40
Tangible Book Value
1,1561,1451,2521,2271,037999.34
Tangible Book Value Per Share
2.482.512.782.732.472.38
Buildings
368.08365.15364.64360.55132.86-
Machinery
176.81152.53118.95110.43108.4763.3
Construction In Progress
---10.13--